Apotex Launches First Generic Version of Merck's Nasonex(R)

TORONTO, March 22, 2016 -- (Healthcare Sales & Marketing Network) - Apotex Inc. announced today that it has launched the first generic version of Merck's Nasonex® nasal spray (mometasone furoate monohydrate) in the United States. Apotex's mometas... Biopharmaceuticals, Generics, Product LaunchApotex, Nasonex, mometasone furoate, Merck
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news